Clinical Trial Update: Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial reports non-inferiority of Norzyme pancreatic enzyme replacement therapy compared with Creon in patients with Exocrine pancreatic ins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exocrine Pancreatic Insufficiency

Drugs mentioned

• Creon (pancrelipase)
• Norzyme (pancrelipase)

Snippet

Sponsor: Azidus Brasil | Conditions: Pancreatic Insufficiency | Phase 2, Phase 3 | Status: UNKNOWN